NDC 72162-1154-01 - Benztropine Mesylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1154
- Requested NDC
- 72162-1154-01
- Package NDCs from labels
- 72162-1154-1, 72162-1154-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2023-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Benztropine Mesylate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1154-1 | Benztropine Mesylate | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 100 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1154 | BENZTROPINE MESYLATE TABLET [BRYANT RANCH PREPACK] | 100 | Current NDC, 1 package rows | 20230531_959363b8-6847-4f6e-9957-6254febb085c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Bryant Ranch Prepack | 284e78af-7544-4c4a-8081-74e45501dc76 | 2026-01-07 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Chartwell RX, LLC. | c002005d-a478-48d4-b345-cb87edcb061f | 2025-12-09 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | American Health Packaging | b7f915a9-cd53-4a74-8ee5-35ee5c5c991e | 2025-11-18 | Warnings, Adverse reactions | ANDA040715 885209 WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | QUAGEN PHARMACEUTICALS LLC | e1f0a249-e660-4592-9ffc-1c02b1022778 | 2025-06-17 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Marlex PHARMACEUTICAL, INC | 31bbcbfa-dc74-99e2-e063-6394a90aa608 | 2025-03-01 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Major Pharmaceuticals | 8b18b66c-2935-4304-8e20-ebf68dee5a1a | 2025-01-16 | Warnings, Adverse reactions | ANDA040715 885209 WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Zydus Pharmaceuticals USA Inc. | ecaeaadf-0847-4605-a205-a674f75f8bb2 | 2024-12-20 | Warnings, Adverse reactions | WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | SUNRISE PHARMACEUTICAL, INC | 2c988462-ce77-4e99-b98e-8f6ad519e295 | 2024-10-16 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Fresenius Kabi USA, LLC | b03bd28e-3b44-41e4-9a7e-28b9d7975245 | 2024-10-11 | Warnings, Adverse reactions | WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Hikma Pharmaceuticals USA Inc. | accd7e33-ca6e-46e6-a2ae-20b9bcd8fb89 | 2024-04-11 | Warnings, Adverse reactions | WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Hikma Pharmaceuticals USA Inc. | 95620f40-5ddf-41b8-80a5-f658248f26f0 | 2024-04-11 | Warnings, Adverse reactions | WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | A-S Medication Solutions | 53b134eb-b341-4fe4-a3ca-90a7da011974 | 2024-01-07 | Warnings, Adverse reactions | ANDA040715 WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Bryant Ranch Prepack | 959363b8-6847-4f6e-9957-6254febb085c | 2023-05-30 | Warnings, Adverse reactions | ANDA040715 72162-1154-1 72162-1154 72162115401 885209 0cd274ca-3c17-4d18-b7d2-31edd8f2c9cf 959363b8-6847-4f6e-9957-6254febb085c WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Leading Pharma, LLC | fe002ec4-07cb-41ca-a58c-33b3a8682101 | 2021-11-14 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | f82c6455-f36b-49d7-881e-6601d513d846 | 2021-01-21 | Warnings, Adverse reactions | WMJ8TL7510 |
| Benztropine Mesylate | BENZTROPINE | Cipla USA Inc. | 3d2732f9-b8a9-4e83-91e7-da616ddcb786 | 2020-05-01 | Warnings, Adverse reactions | 885209 WMJ8TL7510 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Proficient Rx LP | c1044563-2bd2-4f43-a951-25d083b1c679 | 2019-11-01 | Warnings, Adverse reactions | WMJ8TL7510 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.